The cross-sectional association of frailty with past and current exposure to strong anticholinergic drugs
- 12 November 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Aging Clinical and Experimental Research
- Vol. 33 (8), 2283-2289
- https://doi.org/10.1007/s40520-020-01742-6
Abstract
Background Anticholinergic drugs may contribute to frailty by impairing cognitive and physical functions. Strong anticholinergic drugs in particular may have adverse effects among older adults. Objectives Determine the association between frailty and the use of strong anticholinergic drugs among older US Veterans. Methods This is a cross-sectional study of community-dwelling Veterans 65 years and older who had determinations of frailty status. Prescription data for patients using strong anticholinergic medications (never/past/current) was obtained via electronic health records. A 31-item VA Frailty Index (VA-FI) was generated at the time of the assessment. We dichotomized the groups into non-frail (FI = < 0.21) and frail (FI ≥ 0.21) patients. We used binomial logistic regression to calculate odds ratios (ORs) and 95% confidence intervals (CIs). Frailty was the dependent variable and use of strong anticholinergic drugs was the independent variable. Multivariate adjustment was conducted for age, gender, race, ethnicity, marital status, and BMI. Results Population sample consisted of 17,084 Veterans who were 71.05% Caucasian, 97.34% male, and with a mean age 75.60 (SD = 8.04) years. Among the population, 9940 (58.18%) patients had no previous use of strong anticholinergic drugs, whereas 5182 (30.33%) had past exposure and 1962 (11.49%) had current exposure. In binomial logistic regression, individuals with past (OR 3.27, 95% CI 3.03–3.54, p < 0.0005) or current (OR 4.78, 95% CI 4.30–5.31, p < 0.0005) exposure showed a higher association with frailty as compared to individuals who were never exposed. Conclusions Past and current use of strong anticholinergic drugs were associated with frailty in older Veterans. These results suggest that screening for frailty in patients with past or current exposure to strong anticholinergic medications may be necessary for proper management.Keywords
This publication has 37 references indexed in Scilit:
- The Burden of Frailty Among U.S. Veterans and Its Association With Mortality, 2002–2012The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2018
- Frailty and Multimorbidity: A Systematic Review and Meta-analysisThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2018
- Risk factors and protective factors associated with incident or increase of frailty among community-dwelling older adults: A systematic review of longitudinal studiesPLOS ONE, 2017
- Frailty, polypharmacy, and potentially inappropriate medications in old people: findings in a representative sample of the French populationEuropean Journal of Clinical Pharmacology, 2017
- Frailty Is Associated with an Increased Risk of Incident Type 2 Diabetes in the ElderlyJournal of the American Medical Directors Association, 2016
- Effects of Changes in Number of Medications and Drug Burden Index Exposure on Transitions Between Frailty States and Death: The Concord Health and Ageing in Men Project Cohort StudyJournal of the American Geriatrics Society, 2016
- Frailty Defined by Deficit Accumulation and Geriatric Medicine Defined by FrailtyClinics in Geriatric Medicine, 2011
- Frailty in Older Mexican‐American and European‐American Adults: Is There an Ethnic Disparity?Journal of the American Geriatrics Society, 2008
- Untangling the Concepts of Disability, Frailty, and Comorbidity: Implications for Improved Targeting and CareThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2004
- Frailty in Older Adults: Evidence for a PhenotypeThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2001